Innoviva (INVA) Faces A Valuation Test, Is The Discount Too Wide?Simplywall·Aug 26 at 11:22 AMINVA+0.05%
The Infrastructure Illusion: Fusion Energy, IP, and the Messy Tech Back-EndGlobal Report·Aug 12 at 05:12 AMADEA-1.91%WSE-0.61%
Cantor Fitzgerald Lowers Innoviva (NASDAQ:INVA) Price Target to $34.00Market Beat·Aug 7 at 07:48 AMINVA+0.05%
Innoviva (NASDAQ:INVA) Announces Quarterly Earnings Results, Misses Expectations By $1.58 EPSMarket Beat·Aug 5 at 11:41 PMINVA+0.05%
Innoviva | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 119.59 MEarnings Watch·Aug 5 at 03:58 PMINVA+0.05%
Innoviva Q2 FY26 swings to net loss of $83.4 million; revenue rises 19% to $119.6 millionPUBT·Aug 5 at 03:28 PMINVA+0.05%RDY+0.16%
Empowered Funds LLC Purchases 93,424 Shares of Innoviva, Inc. $INVAMarket Beat·Aug 3 at 02:37 AMINVA+0.05%
As Q2 earnings kick off, these small-cap stocks earn an A+ for profitabilityMSN·Jul 17 at 12:21 PMCNNE+1.23%BLKB+0.10%
Innoviva (INVA) Leaves Russell Indexes, Is The Stock Still Cheap?Simplywall·Jul 7 at 11:06 PMINVA+0.05%
Basilea publishes investor presentation on anti-infectives strategy, pipeline focusPUBT·Jun 29 at 11:11 PMINVA+0.05%
Is Innoviva (INVA) Undervalued After Nortiva Bio Launch And XACDURO Deal?Simplywall·Jun 28 at 11:10 AMINVA+0.05%RDY+0.16%
Innoviva unit Nortiva Bio launches to develop monthly long-acting oral medicinesPUBT·Jun 18 at 10:18 AMINVA+0.05%
